vs

Side-by-side financial comparison of JFrog Ltd (FROG) and Kiniksa Pharmaceuticals International, plc (KNSA). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $145.3M, roughly 1.4× JFrog Ltd). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs -10.5%, a 17.5% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 25.2%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $49.9M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 20.4%).

JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

FROG vs KNSA — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.4× larger
KNSA
$202.1M
$145.3M
FROG
Growing faster (revenue YoY)
KNSA
KNSA
+39.8% gap
KNSA
65.0%
25.2%
FROG
Higher net margin
KNSA
KNSA
17.5% more per $
KNSA
7.0%
-10.5%
FROG
More free cash flow
KNSA
KNSA
$3.4M more FCF
KNSA
$53.3M
$49.9M
FROG
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
20.4%
FROG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FROG
FROG
KNSA
KNSA
Revenue
$145.3M
$202.1M
Net Profit
$-15.2M
$14.2M
Gross Margin
77.9%
89.6%
Operating Margin
-14.7%
9.8%
Net Margin
-10.5%
7.0%
Revenue YoY
25.2%
65.0%
Net Profit YoY
34.4%
259.8%
EPS (diluted)
$-0.13
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FROG
FROG
KNSA
KNSA
Q4 25
$145.3M
$202.1M
Q3 25
$136.9M
$180.9M
Q2 25
$127.2M
$156.8M
Q1 25
$122.4M
$137.8M
Q4 24
$116.1M
$122.5M
Q3 24
$109.1M
$112.2M
Q2 24
$103.0M
$108.6M
Q1 24
$100.3M
$79.9M
Net Profit
FROG
FROG
KNSA
KNSA
Q4 25
$-15.2M
$14.2M
Q3 25
$-16.4M
$18.4M
Q2 25
$-21.7M
$17.8M
Q1 25
$-18.5M
$8.5M
Q4 24
$-23.2M
$-8.9M
Q3 24
$-22.9M
$-12.7M
Q2 24
$-14.3M
$-3.9M
Q1 24
$-8.8M
$-17.7M
Gross Margin
FROG
FROG
KNSA
KNSA
Q4 25
77.9%
89.6%
Q3 25
77.4%
88.8%
Q2 25
76.3%
88.1%
Q1 25
75.3%
87.0%
Q4 24
75.4%
85.4%
Q3 24
75.0%
82.1%
Q2 24
78.8%
88.7%
Q1 24
79.5%
86.7%
Operating Margin
FROG
FROG
KNSA
KNSA
Q4 25
-14.7%
9.8%
Q3 25
-15.8%
13.3%
Q2 25
-20.4%
12.9%
Q1 25
-18.8%
9.6%
Q4 24
-21.9%
-15.7%
Q3 24
-27.4%
-8.6%
Q2 24
-18.6%
-0.1%
Q1 24
-16.6%
-20.7%
Net Margin
FROG
FROG
KNSA
KNSA
Q4 25
-10.5%
7.0%
Q3 25
-12.0%
10.2%
Q2 25
-17.0%
11.4%
Q1 25
-15.1%
6.2%
Q4 24
-20.0%
-7.3%
Q3 24
-21.0%
-11.3%
Q2 24
-13.9%
-3.6%
Q1 24
-8.8%
-22.2%
EPS (diluted)
FROG
FROG
KNSA
KNSA
Q4 25
$-0.13
$0.18
Q3 25
$-0.14
$0.23
Q2 25
$-0.19
$0.23
Q1 25
$-0.16
$0.11
Q4 24
$-0.21
$-0.11
Q3 24
$-0.21
$-0.18
Q2 24
$-0.13
$-0.06
Q1 24
$-0.08
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FROG
FROG
KNSA
KNSA
Cash + ST InvestmentsLiquidity on hand
$704.4M
$414.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$887.4M
$567.6M
Total Assets
$1.3B
$763.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FROG
FROG
KNSA
KNSA
Q4 25
$704.4M
$414.1M
Q3 25
$651.1M
$352.1M
Q2 25
$611.7M
$307.8M
Q1 25
$563.5M
$268.3M
Q4 24
$522.0M
$243.6M
Q3 24
$467.8M
$223.8M
Q2 24
$591.3M
$218.8M
Q1 24
$579.6M
$213.6M
Stockholders' Equity
FROG
FROG
KNSA
KNSA
Q4 25
$887.4M
$567.6M
Q3 25
$859.4M
$535.4M
Q2 25
$826.5M
$495.0M
Q1 25
$800.0M
$457.5M
Q4 24
$773.5M
$438.4M
Q3 24
$756.2M
$437.0M
Q2 24
$721.4M
$435.1M
Q1 24
$707.8M
$431.9M
Total Assets
FROG
FROG
KNSA
KNSA
Q4 25
$1.3B
$763.6M
Q3 25
$1.3B
$712.3M
Q2 25
$1.2B
$661.1M
Q1 25
$1.2B
$599.3M
Q4 24
$1.1B
$580.6M
Q3 24
$1.1B
$555.3M
Q2 24
$1.0B
$542.4M
Q1 24
$997.1M
$519.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FROG
FROG
KNSA
KNSA
Operating Cash FlowLast quarter
$50.7M
$53.9M
Free Cash FlowOCF − Capex
$49.9M
$53.3M
FCF MarginFCF / Revenue
34.3%
26.4%
Capex IntensityCapex / Revenue
0.6%
0.3%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FROG
FROG
KNSA
KNSA
Q4 25
$50.7M
$53.9M
Q3 25
$30.2M
$33.7M
Q2 25
$36.1M
$28.1M
Q1 25
$28.8M
$22.3M
Q4 24
$49.1M
$18.8M
Q3 24
$27.6M
$-2.2M
Q2 24
$16.7M
$5.2M
Q1 24
$17.5M
$4.0M
Free Cash Flow
FROG
FROG
KNSA
KNSA
Q4 25
$49.9M
$53.3M
Q3 25
$28.8M
$33.0M
Q2 25
$35.5M
$27.9M
Q1 25
$28.1M
$22.2M
Q4 24
$48.5M
$18.6M
Q3 24
$26.7M
Q2 24
$16.0M
Q1 24
$16.6M
$3.9M
FCF Margin
FROG
FROG
KNSA
KNSA
Q4 25
34.3%
26.4%
Q3 25
21.0%
18.2%
Q2 25
27.9%
17.8%
Q1 25
23.0%
16.1%
Q4 24
41.8%
15.2%
Q3 24
24.5%
Q2 24
15.5%
Q1 24
16.6%
4.9%
Capex Intensity
FROG
FROG
KNSA
KNSA
Q4 25
0.6%
0.3%
Q3 25
1.0%
0.4%
Q2 25
0.5%
0.1%
Q1 25
0.5%
0.1%
Q4 24
0.5%
0.2%
Q3 24
0.9%
0.0%
Q2 24
0.7%
0.0%
Q1 24
0.8%
0.1%
Cash Conversion
FROG
FROG
KNSA
KNSA
Q4 25
3.80×
Q3 25
1.83×
Q2 25
1.58×
Q1 25
2.61×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons